Protein-ligand interactions /

Innovative and forward-looking, this volume focuses on recent achievements in this rapidly progressing field and looks at future potential for development. The first part provides a basic understanding of the factors governing protein-ligand interaction, followed by a comparison of the four key expe...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Gohlke, Holger
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Weinheim : Wiley-VCH, [2012]
Σειρά:Methods and principles in medicinal chemistry ; v. 53.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 06771nam a2200853 4500
001 ocn787843753
003 OCoLC
005 20170124071153.7
006 m o d
007 cr cnu---unuuu
008 120423s2012 gw a ob 001 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d MHW  |d CUS  |d N$T  |d TXA  |d E7B  |d YDXCP  |d OCLCQ  |d COO  |d OCLCF  |d OCLCQ  |d CDX  |d DEBSZ  |d DG1  |d IDEBK  |d OCLCQ  |d AZK  |d DG1  |d GrThAP 
019 |a 794707301  |a 796087106  |a 817084136  |a 961502301  |a 962592128 
020 |a 9783527645978  |q (electronic bk.) 
020 |a 3527645977  |q (electronic bk.) 
020 |a 3527329668 
020 |a 9783527329663 
020 |a 9781280662898  |q (MyiLibrary) 
020 |a 1280662891  |q (MyiLibrary) 
020 |z 9783527645947 
020 |z 3527645942 
020 |z 9783527329663 
029 1 |a AU@  |b 000049569070 
029 1 |a AU@  |b 000049632204 
029 1 |a DEBSZ  |b 431131740 
029 1 |a DKDLA  |b 820120-katalog:000599549 
029 1 |a NLGGC  |b 394011295 
029 1 |a NZ1  |b 14976387 
029 1 |a NZ1  |b 15922085 
035 |a (OCoLC)787843753  |z (OCoLC)794707301  |z (OCoLC)796087106  |z (OCoLC)817084136  |z (OCoLC)961502301  |z (OCoLC)962592128 
037 |a 10.1002/9783527645947  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a QP551  |b .P69598 2012 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
049 |a MAIN 
245 0 0 |a Protein-ligand interactions /  |c edited by Holger Gohlke. 
264 1 |a Weinheim :  |b Wiley-VCH,  |c [2012] 
264 4 |c ©2012 
300 |a 1 online resource (xx, 339 pages) :  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
380 |a Bibliography 
490 1 |a Methods and principles in medicinal chemistry ;  |v v. 53 
504 |a Includes bibliographical references and index. 
520 |a Innovative and forward-looking, this volume focuses on recent achievements in this rapidly progressing field and looks at future potential for development. The first part provides a basic understanding of the factors governing protein-ligand interaction, followed by a comparison of the four key experimental methods (calorimetry, surface plasmon resonance, NMR and X-ray crystallography) used in generating interaction data. The second half of the book is devoted to in-silico methods of modeling and predicting molecular recognition and binding. Here, as elsewhere in the book, emphasis is placed on novel approaches and recent improvements to established methods. The final part looks at unresolved challenges, and the strategies to address them. 
505 0 |a Protein-Ligand Interactions; Contents; List of Contributors; Preface; A Personal Foreword; Part I: Binding Thermodynamics; 1 Statistical Thermodynamics of Binding and Molecular Recognition Models; 1.1 Introductory Remarks; 1.2 The Binding Constant and Free Energy; 1.3 A Statistical Mechanical Treatment of Binding; 1.3.1 Binding in a Square Well Potential; 1.3.2 Binding in a Harmonic Potential; 1.4 Strategies for Calculating Binding Free Energies; 1.4.1 Direct Association Simulations; 1.4.2 The Quasi-Harmonic Approximation; 1.4.3 Estimation of Entropy Contributions to Binding. 
505 8 |a 1.4.4 The MoleculeMechanics Poisson-Boltzmann Surface AreaMethod1.4.5 Thermodynamic Work Methods; 1.4.6 Ligand Decoupling; 1.4.7 Linear Interaction Methods; 1.4.8 Salt Effects on Binding; 1.4.9 Statistical Potentials; 1.4.10 Empirical Potentials; References; 2 Some Practical Rules for the Thermodynamic Optimization of Drug Candidates; 2.1 Engineering Binding Contributions; 2.2 Eliminating Unfavorable Enthalpy; 2.3 Improving Binding Enthalpy; 2.4 Improving Binding Affinity; 2.5 Improving Selectivity; 2.6 Thermodynamic Optimization Plot; Acknowledgments; References. 
505 8 |a 3 Enthalpy-Entropy Compensation as Deduced from Measurements of Temperature Dependence3.1 Introduction; 3.2 The Current Status of Enthalpy-Entropy Compensation; 3.3 Measurement of the Entropy and Enthalpy of Activation; 3.4 An Example; 3.5 The Compensation Temperature; 3.6 Effect of High Correlation on Estimates of Entropy and Enthalpy; 3.7 Evolutionary Considerations; 3.8 Textbooks; References; Part II: Learning from Biophysical Experiments; 4 Interaction Kinetic Data Generated by Surface Plasmon Resonance Biosensors and the Use of Kinetic Rate Constants in Lead Generation and Optimization. 
505 8 |a 4.1 Background4.2 SPR Biosensor Technology; 4.2.1 Principles; 4.2.2 Sensitivity; 4.2.3 Kinetic Resolution; 4.2.4 Performance for Drug Discovery; 4.3 From Interaction Models to Kinetic Rate Constants and Affinity; 4.3.1 Determination of Interaction Kinetic Rate Constants; 4.3.2 Determination of Affinities; 4.3.3 Steady-State Analysis versus Analysis of Complete Sensorgrams; 4.4 Affinity versus Kinetic Rate Constants for Evaluation of Interactions; 4.5 From Models to Mechanisms; 4.5.1 Irreversible Interactions; 4.5.2 Induced Fit; 4.5.3 Conformational Selection. 
505 8 |a 4.5.4 Unified Model for Dynamic Targets4.5.5 Heterogeneous Systems/Parallel Reactions; 4.5.6 Mechanism-Based Inhibitors; 4.5.7 Multiple Binding Sites and Influence of Cofactors; 4.6 Structural Information; 4.7 The Use of Kinetic Rate Constants in Lead Generation and Optimization; 4.7.1 Structure-Kinetic Relationships; 4.7.2 Selectivity/Specificity and Resistance; 4.7.3 Chemodynamics; 4.7.4 Thermodynamics; 4.8 Designing Compounds with Optimal Properties; 4.8.1 Correlation between Kinetic and Thermodynamic Parameters and Pharmacological Efficacy; 4.8.2 Structural Modeling; 4.9 Conclusions. 
588 0 |a Print version record. 
650 0 |a Proteins. 
650 0 |a Ligands (Biochemistry) 
650 0 |a Ligand binding (Biochemistry) 
650 0 |a Drugs  |x Structure-activity relationships. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Drugs  |x Structure-activity relationships.  |2 fast  |0 (OCoLC)fst00898929 
650 7 |a Ligand binding (Biochemistry)  |2 fast  |0 (OCoLC)fst00998460 
650 7 |a Ligands (Biochemistry)  |2 fast  |0 (OCoLC)fst00998471 
650 7 |a Proteins.  |2 fast  |0 (OCoLC)fst01079711 
655 4 |a Electronic books. 
700 1 |a Gohlke, Holger. 
776 0 8 |i Print version:  |t Protein-ligand interactions.  |d Weinheim : Wiley-VCH, ©2012  |z 9783527645978  |w (OCoLC)787843753 
830 0 |a Methods and principles in medicinal chemistry ;  |v v. 53. 
856 4 0 |u https://doi.org/10.1002/9783527645947  |z Full Text via HEAL-Link 
994 |a 92  |b DG1